An extreme form of encryption could solve big data's privacy problem

Fully homomorphic encryption allows us to run analysis on data without ever seeing the contents. It could help us reap the full benefits of big data, from fighting financial fraud to catching diseases early LIKE any doctor, Jacques Fellas wants to give his patients the best care possible. But his instrument of choice is no scalpel or stethoscope, it is far more powerful than that. Hidden inside each of us are genetic markers that can tell doctors like Fellas which individuals are susceptible to diseases such as AIDS, hepatitis and more. If he can learn to read these clues, then Fellas would have advance warning of who requires early treatment.

 This could be life-saving. The trouble is, teasing out the relationships between genetic markers and diseases requires an awful lot of data, more than … 

Fellas Lab – Human Genomics of Infection and Immunity

We use large-scale genomics and bioinformatics to explore the impact of genetic variation on immune parameters and host-pathogen interactions. Our ambition is to shed new light on basic biological mechanisms and to pave the way toward more personalized approaches to medicine. At the crossroad between basic science and the clinical world, we are committed to translational genomic research, aiming at identifying, validating, and bringing to clinical use genetic markers of susceptibility to infectious diseases. 

We use large-scale genomics and bioinformatics to explore the impact of genetic variation on immune parameters and host-pathogen interactions. Our ambition is to shed new light on basic biological mechanisms and to pave the way toward more personalized approaches to medicine. At the crossroad between basic science and the clinical world, we are committed to translational genomic research, aiming at identifying, validating, and bringing to clinical use genetic markers of susceptibility to infectious diseases.

We use large-scale genomics and bioinformatics to explore the impact of genetic variation on immune parameters and host-pathogen interactions. Our ambition is to shed new light on basic biological mechanisms and to pave the way toward more personalized approaches to medicine. At the crossroad between basic science and the clinical world, we are committed to translational genomic research, aiming at identifying, validating, and bringing to clinical use genetic markers of susceptibility to infectious diseases.

We use large-scale genomics and bioinformatics to explore the impact of genetic variation on immune parameters and host-pathogen interactions. Our ambition is to shed new light on basic biological mechanisms and to pave the way toward more personalized approaches to medicine. At the crossroad between basic science and the clinical world, we are committed to translational genomic research, aiming at identifying, validating, and bringing to clinical use genetic markers of susceptibility to infectious diseases.

We use large-scale genomics and bioinformatics to explore the impact of genetic variation on immune parameters and host-pathogen interactions. Our ambition is to shed new light on basic biological mechanisms and to pave the way toward more personalized approaches to medicine. At the crossroad between basic science and the clinical world, we are committed to translational genomic research, aiming at identifying, validating, and bringing to clinical use genetic markers of susceptibility to infectious diseases.